Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Antibiotics in Breast Augmentation
NCT04834310Phase 4Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Apr 2021
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of cefalexin in surgical site infection (SSI), capsular contracture, sponsored by University of California, Los Angeles. Planned start Apr 2021; status: withdrawn.
02
Drugs
cefalexin
03
Conditions
surgical site infection (SSI)capsular contracture
Beyond the preview
Go deeper on NCT04834310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04834310.